Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients

AIDS Research and Human Retroviruses

Volumn 14, Issue 6, 1998, Pages 533-536

  Zipeto, Donato ^a   Hong, Christina ^a   Gerna, Giuseppe ^b   Zavattoni, Maurizio ^b   Katzenstein, David ^a,c   Merigan, Thomas C ^a   Rasmussen, Lucy ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CYTOMEGALOVIRUS; GENE AMPLIFICATION; GENOTYPE; HETEROSEXUALITY; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ABUSE; ITALY; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

EID: 0032502695     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.533     Document Type: Article

References (15)

1. Chandler SH and McDougalI JK: Comparison of restriction site polymorphisms among clinical isolates and laboratory strains of human cytomegalovirus. J Gen Virol 1986;67:2179-2192.
2. Rasmussen L, Resta S, and Merigan T: Human cytomegalovirus glycoprotein-receptor interactions. Transplant Proc 1991; 23:60-63.
3. Rasmussen L: Immune response to human cytomegalovirus infection. Curr Top Microbiol Immunol 1990;154:221-254.
4. Fries BC, Chou S, Boeckh M, and Torok-Storb B: Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994;169:769-774.
5. Meyer-Konig U, et al.: 5th Int. Cytomegalovirus Conf., Stockholm, Sweden, May 1995.
6. Minisrini R, et al.: 6th Int. Cytomegalovirus Conf., Perdido Beach, Alabama, March 1997. Abstract 186.
7. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, and Pergolizzi R: Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996;174:184-187.
8. Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, and Merigan TC: Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997;175:179-184.
9. Quinn TC: AIDS in Africa: Evidence for heterosexual transmission of the human immunodeficiency virus. NY State J Med 1987;87:286-289.
10. Chou S: Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 1992;188:388-390.
11. Chou S and Dennison K: Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1992;166:604-607.
12. Shepp DH, Moses JE, and Kaplan MH: Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: Influence on disease expression and survival. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:460-468.
13. Schrier RD, Wiley CA, Spina C, McCutchan JA, and Grant I: Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center. J clin Invest 1996;98:731-740.
14. Kraat YJ, Christiaans MH, Nieman FH, van den Berg-Loonen PM, van Hooff JP, and Bruggeman CA: Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transplant Int 1994;7:362-367.
15. Chan IS, Neaton JD, Saravolatz LD, Crane LR, and Osterberger J: Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS 1995;9:1145-1151.